Andrew D. Campbell, M.D. | oneSCDvoice
  • Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

Andrew D. Campbell, MD

Comprehensive Sickle Cell Disease Program
Children's National Health System
111 Michigan Avenue, NW
Washington, DC, United States

Dr. Campbell’s distinguished training and career path began at Morehouse College. He continued medical school at Case Western Reserve University and completed post graduate training at Massachusetts General Hospital (Harvard) and Lurie Children’s Hospital (Northwestern University). Prior to joining Children’s National, he was Director of the Comprehensive Sickle Cell Center at the University of Michigan, a position he held since 2005. His research interests span several topics in sickle cell disease including pulmonary complications, fetal hemoglobin switching in transgenic sickle cell mice, phenotype/genotype relationships, and renal complications.

Areas of Interest:
Pulmonary Hypertension in sickle cell disease
Phenotype/genotype Studies within twin and siblings with sickle cell disease
Morbidity and mortality in transitioning sickle cell patients
Fetal hemoglobin switching within sickle cell trangenic mice


Representative Publications:

Differences in the clinical and genotypic presentation of sickle cell disease around the world

An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes

mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease

Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease

Single-session biofeedback-assisted relaxation training in children with sickle cell disease

Hereditary Persistence of Fetal Hemoglobin Caused by Single Nucleotide Promoter Mutations in Sickle Cell Trait and Hb SC Disease